| 1 |
Díaz-perlas C, Oller-salvia B. Chemically Enhanced Peptide and Protein Therapeutics. Pharmaceutics 2023;15:827. [DOI: 10.3390/pharmaceutics15030827] [Reference Citation Analysis]
|
| 2 |
Kónya Z, Tamás I, Bécsi B, Lontay B, Raics M, Timári I, Kövér KE, Erdődi F. Phosphorylated Peptide Derived from the Myosin Phosphatase Target Subunit Is a Novel Inhibitor of Protein Phosphatase-1. Int J Mol Sci 2023;24. [PMID: 36902219 DOI: 10.3390/ijms24054789] [Reference Citation Analysis]
|
| 3 |
Rayala R, Tiller A, Majumder SA, Stacy HM, Eans SO, Nedovic A, McLaughlin JP, Cudic P. Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration. Molecules 2023;28. [PMID: 36838810 DOI: 10.3390/molecules28041822] [Reference Citation Analysis]
|
| 4 |
Holz E, Darwish M, Tesar DB, Shatz-Binder W. A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future. Pharmaceutics 2023;15. [PMID: 36839922 DOI: 10.3390/pharmaceutics15020600] [Reference Citation Analysis]
|
| 5 |
Ishkaeva RA, Salakhieva DV, Garifullin R, Alshadidi R, Laikov AV, Yergeshov AA, Kamalov MI, Abdullin TI. A new triphenylphosphonium-conjugated amphipathic cationic peptide with improved cell-penetrating and ROS-targeting properties. Curr Res Pharmacol Drug Discov 2023;4:100148. [PMID: 36593927 DOI: 10.1016/j.crphar.2022.100148] [Reference Citation Analysis]
|
| 6 |
Bottens RA, Yamada T. Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer. Cancers (Basel) 2022;14. [PMID: 36428639 DOI: 10.3390/cancers14225546] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Sánchez-navarro M, Giralt E. Peptide Shuttles for Blood–Brain Barrier Drug Delivery. Pharmaceutics 2022;14:1874. [DOI: 10.3390/pharmaceutics14091874] [Reference Citation Analysis]
|
| 8 |
Golosov AA, Flyer AN, Monovich LG. Design and Discovery of Orally Bioavailable Macrocycles: Toward Orally Bioavailable Peptide Therapeutics. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch008] [Reference Citation Analysis]
|
| 9 |
Doty AC, Jarvis CM, Munsell EV. Formulation Strategies to Enable Delivery of Therapeutic Peptides across Cell Membranes. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch009] [Reference Citation Analysis]
|
| 10 |
. Editors’ Biographies. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ot001] [Reference Citation Analysis]
|
| 11 |
Sawyer TK, Biswas K. Peptide Drug Discovery Raison d’Etre: Engineering Mindset, Design Rules and Screening Tools. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch001] [Reference Citation Analysis]
|
| 12 |
Adaligil E, Fairbrother WJ. NMR Spectroscopy for Studying Peptide Conformations and Cell Permeability. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch006] [Reference Citation Analysis]
|
| 13 |
Pei D. Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch007] [Reference Citation Analysis]
|
| 14 |
. Subject Index. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ix002] [Reference Citation Analysis]
|
| 15 |
. Title, Copyright, Foreword. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.fw001] [Reference Citation Analysis]
|
| 16 |
Mulligan VK, Hosseinzadeh P. Computational Design of Peptide-Based Binders to Therapeutic Targets. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch003] [Reference Citation Analysis]
|
| 17 |
Ghodge SV, Biswas K, Golosov AA. Preface. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.pr001] [Reference Citation Analysis]
|
| 18 |
Helmling C, Cunningham CN. mRNA Display and Its Growing Potential in the Discovery of De Novo Therapeutic Peptide Candidates. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch002] [Reference Citation Analysis]
|
| 19 |
Kamenik AS, Linker SM, Riniker S. Matching Simulations and Experiments of Conformationally Flexible Cyclic Peptides: Steps toward a Holistic View of Passive Membrane Permeability. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch005] [Reference Citation Analysis]
|
| 20 |
. Approaching the Next Inflection in Peptide Therapeutics: Attaining Cell Permeability and Oral Bioavailability. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417] [Reference Citation Analysis]
|
| 21 |
Duggal R, Hochman J. Optimization of Peptide Drug Exposures for Pharmacological Efficacy: DMPK Considerations. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch010] [Reference Citation Analysis]
|
| 22 |
Sindhikara D, Johnston J. Roles of Conformations on Predictions of Peptide Properties. ACS Symposium Series 2022. [DOI: 10.1021/bk-2022-1417.ch004] [Reference Citation Analysis]
|
